| Title |
Author |
Type |
Date |
Words |
| Roche's Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone. |
|
|
Nov 11, 2019 |
1309 |
| Auto-Injectors Market 2019 Trends, Share, Size, Growth Insight, Competitive Analysis, Statistics, Regional, And Global Forecast To 2022. |
|
|
Oct 31, 2019 |
1082 |
| Auto-Injectors Market Global Size, Share, Growth prospect in the Future, Emerging Technologies, Gross Margin Analysis Till 2022. |
|
|
Oct 22, 2019 |
1056 |
| Auto-Injectors Market 2019 Global Industry Profit Growth, Emerging Technologies, Competitive Landscape and Opportunity Assessment by Forecast 2022. |
|
|
Oct 8, 2019 |
951 |
| FDA approves Roche's Rituxan (rituximab) in children with two rare blood vessel disorders. |
|
|
Sep 30, 2019 |
1207 |
| Interleukin Inhibitors Market Size Is Expected To Reach USD 74.6 Billion By 2026 /Grand View Research Inc. |
|
|
Sep 20, 2019 |
690 |
| Auto-Injectors Market Value 2019 Global Industry Analysis by Size, Share, Trend, Future Growth, Gross Margin, Revenue Till 2023. |
|
|
Sep 18, 2019 |
961 |
| FDA grants Breakthrough Therapy Designation for Roche's Gazyva (obinutuzumab) in Lupus Nephritis. |
|
|
Sep 18, 2019 |
1218 |
| Medicinal Products Containing The Active Substance Tocilizumab. |
|
|
Sep 18, 2019 |
128 |
| Supply Of Medicinal Products Containing The Active Substance Tocilizumab. |
|
|
Sep 17, 2019 |
197 |
| Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis. |
Bes, Cemal |
Disease/Disorder overview |
Sep 1, 2019 |
3427 |
| Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab. |
Carrion-Barbera, Irene; Salman-Monte, Tarek Carlos; Castell, Sonia; Castro-Dominguez, Francisco; Oje |
|
Sep 1, 2019 |
2392 |
| Booster vaccines: Largely safe in immunosuppressed kids. |
Bosworth, Ted |
|
Sep 1, 2019 |
514 |
| The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease. |
Yan, Dong; Liu, JinJing; Zhang, Yuehua; Yuan, Wei; Xu, Yan; Shi, Jing; Li, Chaoran; Wang, Yining; Pe |
|
Sep 1, 2019 |
4720 |
| Etiologic Spectrum and Follow-Up Results of Noninfectious Uveitis in Children: A Single Referral Center Experience. |
Cakan, Mustafa; Ekinci, Dilbade Yildiz; Karadag, Serife Gul; Ayaz, Nuray Aktay |
|
Sep 1, 2019 |
4249 |
| Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis. |
Atas, Nuh; Varan, Ozkan; Babaoglu, Hakan; Satis, Hasan; Salman, Reyhan Bilici; Tufan, Abdurrahman |
|
Sep 1, 2019 |
3174 |
| Australia : $56 million investment in Cancer and Inflammatory Disease medicines. |
|
|
Jul 31, 2019 |
731 |
| Neuromyelitis optica spectrum disorder Market Insights, Trends, Share, and Outlook 2028. |
|
|
Jul 19, 2019 |
1468 |
| United States : Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility. |
|
|
Jul 17, 2019 |
824 |
| Delivery Of The Drug Totsilizumab, Within The Framework Of The Implementation Of The Measures Of The Departmental Targeted Program prevention Of Disability Of The Population Of The Republic Of Karelia In 2019 (subprogram rheumatoid Arthritis ). |
|
|
Jul 17, 2019 |
131 |
| Drug Preparations - 12 Lots: Lot No.1 - Tocilizumab; Lot No.2 - Infliximab; Lot No.3 - Famotidine; Lot # 4 - Octreotide; Lot # 5 - Iron, Parenteralpreparations; Lot # 6 - Valproicacid; Lot # 7 - Metamizolesodium; Lot # 8 - Diphenhydramine; Lot # 9 - Magne. |
|
|
Jul 5, 2019 |
127 |
| Medicines - 4 Lots: Lot # 1 - Tocilizumab; Lot No.2 - Silicones; Lot No.3 - Mono; Lot # 4 - Thioctic Acid. |
|
|
Jul 5, 2019 |
101 |
| Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report. |
Fujita, Yuya; Nawata, Masao; Nagayasu, Atsushi; Someya, Kazuki; Saito, Kazuyoshi; Tanaka, Yoshiya |
|
Jul 1, 2019 |
2909 |
| Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies. |
Chang, Che-Mai; Hsu, Yu-Wen; Wong, Henry Sung-Ching; Wei, James Cheng-Chung; Liu, Xiao; Liao, Hsien- |
|
Jul 1, 2019 |
6238 |
| Delivery Of Medicinal Products Used In Drug Programs By Packet (poland-katowice: Pharmaceutical Products). |
|
|
Jun 20, 2019 |
107 |
| Gilead Sciences (NASDAQ: GILD) - Kite Announces New Yescarta[R] Data From ZUMA-1 -- 3/6/2019. |
|
|
Jun 13, 2019 |
2022 |
| United States : Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia. |
|
|
Jun 7, 2019 |
661 |
| Kite Releases End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia. |
|
|
Jun 4, 2019 |
625 |
| Kite announces new Yescarta data from ZUMA-1. |
|
|
Jun 3, 2019 |
577 |
| Bellicum presents interim data for BPX-601 in Metastatic Pancreatic Cancer. |
|
|
Jun 2, 2019 |
456 |
| Kite announces end of Phase 1 ZUMA-3 results for KTE-X19. |
|
|
Jun 2, 2019 |
340 |
| Accelerated Nodulosis in a Patient With Rheumatoid Arthritis. |
Enginar, Ayse Unal; Nur, Hakan; Gilgil, Erdal; Kacar, Cahit |
|
Jun 1, 2019 |
1922 |
| Canada : B.C. expands use of biosimilars to offer coverage for more treatment options. |
|
|
May 30, 2019 |
798 |
| Chugai Pharmaceutical Co., Ltd. - Chugai's Actemra Intravenous Infusion Receives Additional Approval for Adult Still's Disease -- 22/5/2019. |
|
|
May 28, 2019 |
717 |
| 'I could barely walk and nearly lost my sight - then a drugs trial saved my life' REAL LIFE; When Carol Howell was diagnosed with a debilitating condition, she was willing to take a risk to get her health back. |
|
|
May 5, 2019 |
1482 |
| 'I could barely walk and nearly lost my sight -- then a drug trial saved my life'; When Carol Howell was diagnosed with a debilitating condition, she was willing to take a risk to get her health back... |
|
|
May 5, 2019 |
1647 |
| Treatment goals for children with localized scleroderma. |
Jancin, Bruce |
|
May 1, 2019 |
1220 |
| Gilead Sciences (NASDAQ: GILD) - Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities -- 24/4/2019. |
|
|
Apr 25, 2019 |
1317 |
| Survey on transportation and storage of biological therapies by patients. |
Saavedra, Maira Arias; Aimo, Carolina; Andrade, Jose Astudillo; Alvarez, Damaris; Sequeira, Gabriel; |
Report |
Apr 23, 2019 |
4272 |
| Disseminated hollow and solid lung nodules as a unique pulmonary manifestation of rheumatoid arthritis. |
Jungraithmayr, Wolfgang; Enz, Njanja; Lippek, Frank |
Clinical report |
Apr 23, 2019 |
565 |
| Autolus reports initial results from ALLCAR19 Phase 1/2 trial. |
|
|
Apr 1, 2019 |
251 |
| Switzerland : European Commission approves Roches MabThera (rituximab) for a rare autoimmune disease. |
|
|
Mar 18, 2019 |
889 |
| Supply Of Medicines Whose Active Principle Is Tocilizumab For The Hospitals Of The Zamora Healthcare Complex, Belonging To The Health Care Management Of Zamora. |
|
|
Mar 9, 2019 |
131 |
| Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy. |
Cerda, Osvaldo Luis; Correa, Maria De Los Angeles; Granel, Amelia; Marcos, Ana Ines; Giraldo, Claudi |
Report |
Mar 1, 2019 |
3475 |
| Algorithm addresses TNF inhibitor-induced psoriasis. |
Craven, Jeff |
Drug overview |
Feb 1, 2019 |
744 |
| Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF. |
Yilmaz, Sedat; Tekgoz, Emre; Cinar, Muhammet |
|
Dec 1, 2018 |
2194 |
| Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis. |
Choi, In Ah; Lee, Sang Jin; Park, Won; Park, Sung Hwan; Shim, Seung-cheol; Baek, Han Joo; Yoo, Dae-H |
|
Dec 1, 2018 |
3193 |
| Combo Therapy Not Needed If Low RA Disease Activity Achieved; Dropping methotrexate, continuing tocilizumab does not lead to worsening of disease activity. |
|
|
Sep 26, 2018 |
261 |
| Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. |
Jacobs, Ben; Jawad, Ali; Fattah, Zozik |
|
Sep 1, 2018 |
1709 |
| Comparacion de citocinas plasmaticas antes y despues del tratamiento con rituximab en pacientes con artritis reumatoide y lupus eritematoso sistemico asociado a poliautoinmunidad. |
Barahona Correa, Julian Esteban; Franco Cortes, Manuel Antonio; Uribe, Juana Angel; Rodriguez Camach |
|
Jul 1, 2018 |
8029 |
| OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS. |
Balameena, S.; Ravichandran, R. |
Report |
Jun 4, 2018 |
1612 |
| Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis. |
Kim, Seong Kyu; Choe, Jung Yoon |
|
Jun 1, 2018 |
4076 |
| Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. |
Einecke, Gunilla; Brasen, Jan Hinrich; Hanke, Nils; Haller, Hermann; Schwarz, Anke |
Disease/Disorder overview |
Jan 1, 2018 |
4179 |
| Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. |
Turck, Natacha; Eperon, Simone; Gracia, Maria De Los Angeles; Oberic, Aurelie; Hamedani, Mehrad |
|
Jan 1, 2018 |
7276 |
| Rituximab Induced Pulmonary Edema Managed with Extracorporeal Life Support. |
Miller, Jacob R.; Isakow, Warren; Masood, Muhammad F.; Aguilar, Patrick; Sanfilippo, Kristen M.; Bal |
|
Jan 1, 2018 |
2452 |
| Myokines as Possible Therapeutic Targets in Cancer Cachexia. |
Manole, Emilia; Ceafalan, Laura C.; Popescu, Bogdan O.; Dumitru, Carmen; Bastian, Alexandra E. |
|
Jan 1, 2018 |
6715 |
| Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies. |
Sun, Shangjun; Hao, He; Yang, Ge; Zhang, Yi; Fu, Yang |
|
Jan 1, 2018 |
7613 |
| Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome. |
Shamriz, Oded; Tal, Yuval; Gross, Menachem |
|
Jan 1, 2018 |
5574 |
| Immune System and Chronic Diseases 2018. |
Bagatini, Margarete Dulce; Cardoso, Andreia Machado; Reschke, Cristina Ruedell; Carvalho, Fabiano Ba |
|
Jan 1, 2018 |
1369 |
| NRF2 Activation Inhibits Both TGF-[beta]1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment. |
Mitamura, Yasutaka; Murai, Mika; Mitoma, Chikage; Furue, Masutaka |
|
Jan 1, 2018 |
5628 |
| A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge. |
Hashmi, Hamza; Murray, Drew; Greenwell, John; Shaikh, Marwan; Basu, Soumit; Krem, Maxwell |
|
Jan 1, 2018 |
3240 |
| Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis. |
Figueiredo-Braga, Margarida; Cornaby, Caleb; Cortez, Alice; Bernardes, Miguel; Terroso, Georgina; Fi |
|
Jan 1, 2018 |
7386 |
| Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results. |
Navarini, Luca; Bisogno, Tiziana; Margiotta, Domenico Paolo Emanuele; Piccoli, Alessandra; Angeletti |
|
Jan 1, 2018 |
3764 |
| Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. |
O'Dwyer, Ronan; Kovaleva, Marina; Zhang, Jiquan; Steven, John; Cummins, Emma; Luxenberg, Deborah; Da |
|
Jan 1, 2018 |
7681 |
| Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis. |
Xu, Nuo; Cui, Yi; Xie, Tianlu; Zheng, Mi |
Clinical report |
Jan 1, 2018 |
7131 |
| Tocilizumab for the Treatment of Mevalonate Kinase Deficiency. |
Rafiq, Nadia K.; Lachmann, Helen; Joensen, Frodi; Herlin, Troels; Brogan, Paul A. |
|
Jan 1, 2018 |
3551 |
| Endobronchial Watanabe Spigots for Treatment of Pyopneumothorax due to Nontuberculous Mycobacteriosis in a Patient with Rheumatoid Arthritis: A Case Report Based on Past Experience. |
Kawai, Norikazu; Kawaguchi, Takeshi; Tojo, Takashi; Osa, Takao; Yamamoto, Yoshifumi; Yasukawa, Motoa |
|
Jan 1, 2018 |
1664 |
| Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome. |
Cruz-Perez, Franchesca; Vila, Salvador; Rios, Grissel; Vila, Luis M. |
|
Jan 1, 2018 |
2829 |
| A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment. |
Filippini, M.; Cartella, S.; Bonzanini, O.; Morello, E.; Tincani, A. |
|
Jan 1, 2018 |
1881 |
| Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. |
Ikeuchi, Hidekazu; Koinuma, Kana; Nakasatomi, Masao; Sakairi, Toru; Kaneko, Yoriaki; Maeshima, Akito |
|
Jan 1, 2018 |
3132 |
| Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment. |
Cacciapaglia, Fabio; Anelli, Maria Grazia; Rinaldi, Angela; Fornaro, Marco; Lopalco, Giuseppe; Scios |
|
Jan 1, 2018 |
5416 |
| AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis. |
Bird, Paul; Peterfy, Charles; Countryman, Peter; Griffiths, Hedley; Barrett, Rina; Youssef, Peter; J |
Clinical report |
Jan 1, 2018 |
6219 |
| High Disease Activity May Increase Fear-Avoidance Beliefs in Rheumatoid Arthritis. |
Tezcan, Mehmet Engin; Dogan, Berfu Cinkit; Sen, Nesrin; Sargin, Mehmet |
Report |
Dec 1, 2017 |
7474 |
| Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab. |
Miao, Shiwei; Fan, Li; Zhao, Liang; Ding, Ding; Liu, Xiaohui; Wang, Haibin; Tan, Wen-Song |
Report |
Jan 1, 2017 |
7644 |
| Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy. |
van Duin, David; Miranda, Cyndee; Husni, Elaine |
Case study |
Apr 1, 2011 |
1350 |
| Genentech gets FDA clearance for rheumatoid arthritis drug. |
|
|
Feb 15, 2010 |
482 |
| Roche Holding AG's experimental rheumatoid arthritis drug Actemra significantly inhibited joint damage progression, according to one-year data from a two-year late stage clinical trial, the Swiss drugmaker said. |
|
Brief article |
Nov 3, 2008 |
199 |
| Tocilizumab superior to methotrexate for RA. |
Walsh, Nancy |
Clinical report |
Sep 15, 2008 |
568 |
| Refractory RA appears to respond to Tocilizumab. |
Walsh, Nancy |
Clinical report |
Sep 15, 2008 |
560 |
